Genenta Science S.p.A. reported earnings results for the half year ended June 30, 2023. For the half year, the company reported net loss was EUR 6.76 million compared to EUR 2.11 million a year ago. Basic loss per share from continuing operations was EUR 0.37 compared to EUR 0.12 a year ago.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
3.3 USD | +3.77% | +3.45% | -33.33% |
May. 06 | Genenta Science S.p.A. Announces New Board Appointments | CI |
Apr. 08 | Genenta Science S.P.A. Announces Resignation of Board Members | CI |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-33.33% | 60.36M | |
+51.85% | 57.87B | |
+41.22% | 40.25B | |
-5.25% | 39.94B | |
-5.16% | 28.54B | |
+12.79% | 26.4B | |
-20.18% | 19.33B | |
+30.88% | 12.4B | |
+0.61% | 12.23B | |
+25.06% | 12.2B |
- Stock Market
- Equities
- GNTA Stock
- News Genenta Science S.p.A.
- Genenta Science S.p.A. Reports Earnings Results for the Half Year Ended June 30, 2023